Data Cross-border Transfer for Pharmaceutical Companies

文章预览

Authors: Jerry Liu | Charles Wu Editor: Kevin Wang Pharmaceutical companies naturally hold and process large amounts of data and personal information due to their industry and business attributes. There are regulatory requirements in different dimensions, especially shown by the recent cases of regulatory penalties and guiding documents in relation to the cross-border transfer scenarios of relevant data. Pharmaceutical companies need to be aware that they may be subject to regulatory requirements in various dimensions, such as administration of human genetic resources protection, data security, personal information protection etc. Any mishandling or negligence may trigger penalties, thereby resulting in compliance risks and losses. This article discusses the regulatory landscape of cross-border transfer of data in the context of data governance of pharmaceutical companies in light of recent legislative and regulatory developments for readers’ reference. I. Regulatory Requirements fro ………………………………